-
1
-
-
1642499237
-
Reboxetine: A norepinephrine selective reuptake pump inhibitor
-
Preskorn SH. Reboxetine: A norepinephrine selective reuptake pump inhibitor. J Psychiatr Practice 2004;10:57-63.
-
(2004)
J Psychiatr Practice
, vol.10
, pp. 57-63
-
-
Preskorn, S.H.1
-
2
-
-
1642423852
-
Milnacipran: A dual norepinephrine and serotonin reuptake pump inhibitor
-
Preskorn SH. Milnacipran: A dual norepinephrine and serotonin reuptake pump inhibitor. J Psychiatr Pract 2004;10:119-26.
-
(2004)
J Psychiatr Pract
, vol.10
, pp. 119-126
-
-
Preskorn, S.H.1
-
3
-
-
0029588298
-
Novel French antidepressants not available in the United States
-
Mitchell PB. Novel French antidepressants not available in the United States. Psychopharmacol Bull 1995;31:509-19.
-
(1995)
Psychopharmacol Bull
, vol.31
, pp. 509-519
-
-
Mitchell, P.B.1
-
4
-
-
0035067929
-
Tianeptine: A review of its use in depressive disorders
-
Wagstaff AJ, Ormrod D, Spencer CM. Tianeptine: A review of its use in depressive disorders. CNS Drugs 2001;15:231-59.
-
(2001)
CNS Drugs
, vol.15
, pp. 231-259
-
-
Wagstaff, A.J.1
Ormrod, D.2
Spencer, C.M.3
-
5
-
-
0028114262
-
Can a serotonin uptake agonist be an authentic antidepressant? Results of a multicenter, multinational therapeutic trial
-
Kamoun A, Delalleau B, Ozun M, Can a serotonin uptake agonist be an authentic antidepressant? Results of a multicenter, multinational therapeutic trial. Encephale 1994;20:521-5.
-
(1994)
Encephale
, vol.20
, pp. 521-525
-
-
Kamoun, A.1
Delalleau, B.2
Ozun, M.3
-
6
-
-
0038449870
-
Modern drug development and the Human Genome Project
-
Series of columns published
-
Preskorn SH. Modern drug development and the Human Genome Project. Series of columns published in the Journal of Psychiatric Practice (www.preskorn.com/column4/html).
-
Journal of Psychiatric Practice
-
-
Preskorn, S.H.1
-
7
-
-
4644333352
-
The case studies series
-
Series of columns published
-
Preskorn SH. The case studies series. Series of columns published in the Journal of Psychiatric Practice (www.preskorn.com/column1/html).
-
Journal of Psychiatric Practice
-
-
Preskorn, S.H.1
-
8
-
-
0036599358
-
Molecular biology of serotonin receptors structure and function at the molecular level
-
Kroeze WK, Kristiansen K, Roth BL. Molecular biology of serotonin receptors structure and function at the molecular level. Curr Top Med Chem 2002;2:507-28.
-
(2002)
Curr Top Med Chem
, vol.2
, pp. 507-528
-
-
Kroeze, W.K.1
Kristiansen, K.2
Roth, B.L.3
-
9
-
-
0026543136
-
Neurochemical and pharmacological properties for tianeptine, a novel antidepressant
-
Labrid C, Mocaer E, Kamoun A. Neurochemical and pharmacological properties for tianeptine, a novel antidepressant. Br J Psychiatry Suppl 1992;15:56-60.
-
(1992)
Br J Psychiatry Suppl
, vol.15
, pp. 56-60
-
-
Labrid, C.1
Mocaer, E.2
Kamoun, A.3
-
10
-
-
0030967548
-
Effects of the (+) and (-) enantiomers of the antidepressant drug tianeptine on 5-HTP-induced behavior
-
Oluyomi AO, Datla KP, Curzon G. Effects of the (+) and (-) enantiomers of the antidepressant drug tianeptine on 5-HTP-induced behavior. Neuropharmacology 1997;36:383-7.
-
(1997)
Neuropharmacology
, vol.36
, pp. 383-387
-
-
Oluyomi, A.O.1
Datla, K.P.2
Curzon, G.3
-
11
-
-
0023795361
-
Neurochemical profile of tianeptine, a new antidepressant drug
-
Kato G, Weitsh AF. Neurochemical profile of tianeptine, a new antidepressant drug. Clin Neuropharmacol 1988;11:S43-S50.
-
(1988)
Clin Neuropharmacol
, vol.11
-
-
Kato, G.1
Weitsh, A.F.2
-
12
-
-
0032958039
-
Although chemically related to amineptine, the antidepressant tianeptine is not a dopamine uptake inhibitor
-
Vaugeois JM, Corera AT, Deslandes A, et al. Although chemically related to amineptine, the antidepressant tianeptine is not a dopamine uptake inhibitor. Pharmacol Biochem Behav 1993;63:285-90.
-
(1993)
Pharmacol Biochem Behav
, vol.63
, pp. 285-290
-
-
Vaugeois, J.M.1
Corera, A.T.2
Deslandes, A.3
-
14
-
-
0026594688
-
In vivo studies on the enhancement of serotonin reuptake by tianeptine
-
De Simoni MG, De Luigi A, Clavenna A, et al. In vivo studies on the enhancement of serotonin reuptake by tianeptine. Brain Res 1992;574:93-7.
-
(1992)
Brain Res
, vol.574
, pp. 93-97
-
-
De Simoni, M.G.1
De Luigi, A.2
Clavenna, A.3
-
15
-
-
0030583630
-
Effects of tianeptine, sertraline and clomipramine on brain serotonin metabolism: A voltammetric approach in the rat
-
Marinesco S, Poncet L, Debilly G, et al. Effects of tianeptine, sertraline and clomipramine on brain serotonin metabolism: A voltammetric approach in the rat. Brain Res 1996;736:82-90.
-
(1996)
Brain Res
, vol.736
, pp. 82-90
-
-
Marinesco, S.1
Poncet, L.2
Debilly, G.3
-
16
-
-
0028811425
-
Tianeptine treatment induces regionally specific changes in monoamines
-
Frankfurt M, McKittrick CR, McEwen BS, et al. Tianeptine treatment induces regionally specific changes in monoamines. Brain Res 1995;696:1-6.
-
(1995)
Brain Res
, vol.696
, pp. 1-6
-
-
Frankfurt, M.1
McKittrick, C.R.2
McEwen, B.S.3
-
17
-
-
0026596356
-
Tianeptine increases the extracellular concentration of dopamine in the nucleus
-
Invernizzi G, Pozzi L, Garattini S, et al. Tianeptine increases the extracellular concentration of dopamine in the nucleus. Neuropharmacology 1992;31:221-7.
-
(1992)
Neuropharmacology
, vol.31
, pp. 221-227
-
-
Invernizzi, G.1
Pozzi, L.2
Garattini, S.3
-
18
-
-
0027223154
-
Tianeptine raises dopamine and blocks stress-induced noradrenaline release in the rat frontal cortex
-
Sacchetti G, Bonini I, Waeterloos GC, et al. Tianeptine raises dopamine and blocks stress-induced noradrenaline release in the rat frontal cortex. Eur J Pharm 1993;236:171-5.
-
(1993)
Eur J Pharm
, vol.236
, pp. 171-175
-
-
Sacchetti, G.1
Bonini, I.2
Waeterloos, G.C.3
-
19
-
-
0024424814
-
Tianeptine an uncommon psychotropic drug
-
Kamoun A, Labrid C, Mocaer E, et al. Tianeptine an uncommon psychotropic drug. Encephale 1989;15:419-22.
-
(1989)
Encephale
, vol.15
, pp. 419-422
-
-
Kamoun, A.1
Labrid, C.2
Mocaer, E.3
-
20
-
-
0028859089
-
Effect of acute and prolonged tianeptine administration on the 5-HT transporter: Electrophysiological, biochemical and radioligand binding studies in the rat brain
-
Pineyro G, Deveault L, Blier P, et al. Effect of acute and prolonged tianeptine administration on the 5-HT transporter: Electrophysiological, biochemical and radioligand binding studies in the rat brain. Naunyn Schmiedebergs Arch Pharmacol 1995;351:111-8.
-
(1995)
Naunyn Schmiedebergs Arch Pharmacol
, vol.351
, pp. 111-118
-
-
Pineyro, G.1
Deveault, L.2
Blier, P.3
-
21
-
-
0026562301
-
Effect of tianeptine on the central cholinergic system: Involvement of serotonin
-
Bertorelli R, Amoroso D, Girotti P, et al. Effect of tianeptine on the central cholinergic system: Involvement of serotonin. Naunyn Schmiedebergs Arch Pharmacol 1992;345:276-81.
-
(1992)
Naunyn Schmiedebergs Arch Pharmacol
, vol.345
, pp. 276-281
-
-
Bertorelli, R.1
Amoroso, D.2
Girotti, P.3
-
22
-
-
0028872542
-
Effect of prolonged administration of tianeptine on 5-HT neurotransmission: An electrophysiological study in the rat hippocampus and dorsal raphe
-
Pineyro G, Deveault L, de Montigny C, et al. Effect of prolonged administration of tianeptine on 5-HT neurotransmission: An electrophysiological study in the rat hippocampus and dorsal raphe. Naunyn Schmiedebergs Arch Pharmacol 1995;351:119-25.
-
(1995)
Naunyn Schmiedebergs Arch Pharmacol
, vol.351
, pp. 119-125
-
-
Pineyro, G.1
Deveault, L.2
De Montigny, C.3
-
23
-
-
0027176015
-
Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin
-
Watanabe Y, Sakai RR, McEwen BS, et al. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin. Brain Res 1993;615:87-94.
-
(1993)
Brain Res
, vol.615
, pp. 87-94
-
-
Watanabe, Y.1
Sakai, R.R.2
McEwen, B.S.3
-
24
-
-
0028365982
-
Tianeptine decreases both serotonin transporter mRNA and binding sites in rat brain
-
Kuroda Y, Watanabe A, McEwen B. Tianeptine decreases both serotonin transporter mRNA and binding sites in rat brain. Eur J Pharmacol 1994;268:R3-R5
-
(1994)
Eur J Pharmacol
, vol.268
-
-
Kuroda, Y.1
Watanabe, A.2
McEwen, B.3
-
25
-
-
0025880532
-
The novel antidepressant tianeptine reduces stress-evoked stimulation of the hypothalamo-pituitary-adrenal axis
-
Delbende C, Contesse V, Mocaer E, et al. The novel antidepressant tianeptine reduces stress-evoked stimulation of the hypothalamo-pituitary- adrenal axis. Eur J Clin Pharmacol 1991;202:391-6.
-
(1991)
Eur J Clin Pharmacol
, vol.202
, pp. 391-396
-
-
Delbende, C.1
Contesse, V.2
Mocaer, E.3
-
26
-
-
0027953335
-
Effect of chronic treatment with the antidepressant tianeptine on the hypethalamo-pituitary-adrenal axis
-
Delbende C, Tranchand Bunel D, Tarozzo G, et al. Effect of chronic treatment with the antidepressant tianeptine on the hypethalamo-pituitary- adrenal axis. Eur J Pharmacol 1994;251:245-51.
-
(1994)
Eur J Pharmacol
, vol.251
, pp. 245-251
-
-
Delbende, C.1
Tranchand Bunel, D.2
Tarozzo, G.3
-
27
-
-
0027317182
-
Antagonism by citalopram and tianeptine of presynaptic 5-HTiB heteroreceptors inhibiting acetylcholine release
-
Bolanos-Jimenez F, de Castro RM, Fillion G. Antagonism by citalopram and tianeptine of presynaptic 5-HTiB heteroreceptors inhibiting acetylcholine release. Eur J Pharmacol 1993;242:1-6.
-
(1993)
Eur J Pharmacol
, vol.242
, pp. 1-6
-
-
Bolanos-Jimenez, F.1
De Castro, R.M.2
Fillion, G.3
-
28
-
-
0030447110
-
Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment
-
Conrad C, Galea LA, Kuroda Y, et al. Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment. Behav Neurosci 1996;110:1321-34.
-
(1996)
Behav Neurosci
, vol.110
, pp. 1321-1334
-
-
Conrad, C.1
Galea, L.A.2
Kuroda, Y.3
-
29
-
-
0028096579
-
The effect of tianeptine and sertraline in three models of depression
-
Kelly JP, Leonard BE. The effect of tianeptine and sertraline in three models of depression. Neuropharmacology 1994;33:1011-6.
-
(1994)
Neuropharmacology
, vol.33
, pp. 1011-1016
-
-
Kelly, J.P.1
Leonard, B.E.2
-
31
-
-
0026538344
-
Influence of the novel antidepressant tianeptine on neurochemical neuroendocrinological and behavioral effects of stress in rats
-
Borqua P, Baudrie V, Laude D, et al. Influence of the novel antidepressant tianeptine on neurochemical neuroendocrinological and behavioral effects of stress in rats. Biol Psychiatry 1992;31:391-400.
-
(1992)
Biol Psychiatry
, vol.31
, pp. 391-400
-
-
Borqua, P.1
Baudrie, V.2
Laude, D.3
-
32
-
-
0035118649
-
Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1beta in the rat
-
Castanon N, Bluthe RM, Dantzer R. Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1beta in the rat. Psychopharmacology 2001;154:50-60.
-
(2001)
Psychopharmacology
, vol.154
, pp. 50-60
-
-
Castanon, N.1
Bluthe, R.M.2
Dantzer, R.3
-
33
-
-
0033913717
-
Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription-a possible mechanism
-
Budziszewska B, Jaworska-Feil L, Kajta M, et al. Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription-a possible mechanism. Br J Pharmacol 2000;130:1385-93.
-
(2000)
Br J Pharmacol
, vol.130
, pp. 1385-1393
-
-
Budziszewska, B.1
Jaworska-Feil, L.2
Kajta, M.3
-
34
-
-
0032529086
-
Effect of chronic restraint stress and tianeptine on growth factors, growth-associated protein-43 and microtubule-associated protein 2 mRNA expression in the rat hippocampus
-
Kuroda Y, McEwen BS. Effect of chronic restraint stress and tianeptine on growth factors, growth-associated protein-43 and microtubule-associated protein 2 mRNA expression in the rat hippocampus. Brain Res Mol Brain Res 1998;59:35-9.
-
(1998)
Brain Res Mol Brain Res
, vol.59
, pp. 35-39
-
-
Kuroda, Y.1
McEwen, B.S.2
-
35
-
-
0343750698
-
Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy
-
Conrad C, LeDoux JE, Magarinos AM, et al. Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy. Behav Neurosci 1999;113:902-13.
-
(1999)
Behav Neurosci
, vol.113
, pp. 902-913
-
-
Conrad, C.1
LeDoux, J.E.2
Magarinos, A.M.3
-
36
-
-
0026493735
-
Tianeptine attenuates stress-induced morphological changes in the hippocampus
-
Watanabe Y, Gould E, Daniels DC, et al. Tianeptine attenuates stress-induced morphological changes in the hippocampus. Eur J Pharmacol 2003;222:157-62.
-
(2003)
Eur J Pharmacol
, vol.222
, pp. 157-162
-
-
Watanabe, Y.1
Gould, E.2
Daniels, D.C.3
-
37
-
-
0030693199
-
Prevention of stress-induced morphological and cognitive consequences
-
McEwen BS, Conrad C, Kuroda Y, et al. Prevention of stress-induced morphological and cognitive consequences. Eur Neuropsychopharmacol 1997;7:S323-S328
-
(1997)
Eur Neuropsychopharmacol
, vol.7
-
-
McEwen, B.S.1
Conrad, C.2
Kuroda, Y.3
-
38
-
-
0345465716
-
Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress
-
Magarinos AM, Deslandes A, McEwen BS. Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. Eur J Pharmacol 1999;371:113-22.
-
(1999)
Eur J Pharmacol
, vol.371
, pp. 113-122
-
-
Magarinos, A.M.1
Deslandes, A.2
McEwen, B.S.3
-
39
-
-
0026048017
-
Comparative study of the effects of tianeptine and other antidepressants on the activity of medial septal neurons in rats anesthetized with urethane
-
Bassant MH, Lee BH, Jazat F, et al. Comparative study of the effects of tianeptine and other antidepressants on the activity of medial septal neurons in rats anesthetized with urethane. Naunyn Schmiedebergs Arch Pharmacol 1991;344:568-73.
-
(1991)
Naunyn Schmiedebergs Arch Pharmacol
, vol.344
, pp. 568-573
-
-
Bassant, M.H.1
Lee, B.H.2
Jazat, F.3
-
40
-
-
0033969785
-
Behavioural effects of fluoxetine and tianeptine, two antidepressants with opposite action mechanisms, in rats
-
Nowakowska E, Kus K, Chodera A, et al. Behavioural effects of fluoxetine and tianeptine, two antidepressants with opposite action mechanisms, in rats. Arzneimittelforschung 2000;50:5-10.
-
(2000)
Arzneimittelforschung
, vol.50
, pp. 5-10
-
-
Nowakowska, E.1
Kus, K.2
Chodera, A.3
-
41
-
-
0024470867
-
Metabolic activation of the antidepressant tianeptine. I. Cytochrome P-450-mediated in vitro covalent binding
-
Letteron P, Descatoire V, Tinel M, et al. Metabolic activation of the antidepressant tianeptine. I. Cytochrome P-450-mediated in vitro covalent binding. Biochem Pharmacol 1998;38:3241-6.
-
(1998)
Biochem Pharmacol
, vol.38
, pp. 3241-3246
-
-
Letteron, P.1
Descatoire, V.2
Tinel, M.3
-
42
-
-
0025362989
-
Metabolic activation of the new tricyclic antidepressant tianeptine by human liver cytochrome P450
-
Larrey D, Tinel M, Letteron P, et al. Metabolic activation of the new tricyclic antidepressant tianeptine by human liver cytochrome P450. Biochem Pharmacol 1990;40:545-50.
-
(1990)
Biochem Pharmacol
, vol.40
, pp. 545-550
-
-
Larrey, D.1
Tinel, M.2
Letteron, P.3
-
43
-
-
0024463752
-
Metabolic activation of the antidepressant tianeptine. II. In vivo covalent binding and toxicological studies at sublethal doses
-
Letteron P, Labbe G, Descatoire V, et al. Metabolic activation of the antidepressant tianeptine. II. In vivo covalent binding and toxicological studies at sublethal doses. Biochem Pharmacol 1989;38:3247-51.
-
(1989)
Biochem Pharmacol
, vol.38
, pp. 3247-3251
-
-
Letteron, P.1
Labbe, G.2
Descatoire, V.3
-
44
-
-
0024433707
-
Tianeptine, a new tricyclic antidepressant metabolized by beta-oxidation of its heptamoic side chain, inhibits the mitochondrial oxidation of medium and short chain fatty acids in mice
-
Fromenty B, Freneaux E, Labbe G, et al. Tianeptine, a new tricyclic antidepressant metabolized by beta-oxidation of its heptamoic side chain, inhibits the mitochondrial oxidation of medium and short chain fatty acids in mice. Biochem Pharmacol 1989;38:3743-51.
-
(1989)
Biochem Pharmacol
, vol.38
, pp. 3743-3751
-
-
Fromenty, B.1
Freneaux, E.2
Labbe, G.3
-
45
-
-
0029127584
-
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity
-
Fromenty B, Pessayre D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther 1995;67:101-54.
-
(1995)
Pharmacol Ther
, vol.67
, pp. 101-154
-
-
Fromenty, B.1
Pessayre, D.2
-
46
-
-
0023714987
-
Pharmacokinetic and metabolic parameters of tianeptine in healthy volunteers and in populations with risk factors
-
Royer RJ, Albin H, Barrucand D, et al. Pharmacokinetic and metabolic parameters of tianeptine in healthy volunteers and in populations with risk factors. Clin Neuropharmacol 1988;11:S90-S96.
-
(1988)
Clin Neuropharmacol
, vol.11
-
-
Royer, R.J.1
Albin, H.2
Barrucand, D.3
-
47
-
-
0024229172
-
Influence of food on tianeptine and its main metabolic kinetics
-
Dresse A, Rosen JM, Brems H, et al. Influence of food on tianeptine and its main metabolic kinetics. J Clin Pharmacol 1988;28:1115-9.
-
(1988)
J Clin Pharmacol
, vol.28
, pp. 1115-1119
-
-
Dresse, A.1
Rosen, J.M.2
Brems, H.3
-
48
-
-
0025321527
-
Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure
-
Zini R, Morin D, Salvadori C, et al. Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure. Br J Clin Pharmacol 1990;29:9-18.
-
(1990)
Br J Clin Pharmacol
, vol.29
, pp. 9-18
-
-
Zini, R.1
Morin, D.2
Salvadori, C.3
-
49
-
-
0025053563
-
The metabolic pathways of tianeptine, a new antidepressant, in healthy volunteers
-
Grislain L, Gele P, Bertrand M, et al. The metabolic pathways of tianeptine, a new antidepressant, in healthy volunteers. Drug Metab Dispos 1990;18:804-8.
-
(1990)
Drug Metab Dispos
, vol.18
, pp. 804-808
-
-
Grislain, L.1
Gele, P.2
Bertrand, M.3
-
50
-
-
0024632803
-
Tianeptine and its main metabolite pharmacokinetics in chronic alcoholism and cirrhosis
-
Royer RJ, Royer-Morrot MJ, Paille F, et al. Tianeptine and its main metabolite pharmacokinetics in chronic alcoholism and cirrhosis. Clin Pharmacokinet 1989;16:186-91.
-
(1989)
Clin Pharmacokinet
, vol.16
, pp. 186-191
-
-
Royer, R.J.1
Royer-Morrot, M.J.2
Paille, F.3
-
51
-
-
0026101287
-
The influence of various drugs on the binding of tianeptine to human plasma proteins
-
Zini R, Morin D, Salvadori C, et al. The influence of various drugs on the binding of tianeptine to human plasma proteins. Int J Clin Pharmacol Ther Toxicol 1991;29:64-6.
-
(1991)
Int J Clin Pharmacol Ther Toxicol
, vol.29
, pp. 64-66
-
-
Zini, R.1
Morin, D.2
Salvadori, C.3
-
52
-
-
0025319596
-
The pharmacokinetics of the antidepressant tianeptine and its main metabolite in healthy humans-influence of alcohol co-administration
-
Salvadori C, Ward C, Defrance R, et al. The pharmacokinetics of the antidepressant tianeptine and its main metabolite in healthy humans-influence of alcohol co-administration. Fundam Clin Pharmacol 1990;4:115-25.
-
(1990)
Fundam Clin Pharmacol
, vol.4
, pp. 115-125
-
-
Salvadori, C.1
Ward, C.2
Defrance, R.3
-
53
-
-
0026059882
-
Pharmacokinetics of the antidepressant tianeptine at steady state in the elderly
-
Demotes-Mainard F, Galley P, Manciet G, et al. Pharmacokinetics of the antidepressant tianeptine at steady state in the elderly. J Clin Pharmacol 1991;31:174-8.
-
(1991)
J Clin Pharmacol
, vol.31
, pp. 174-178
-
-
Demotes-Mainard, F.1
Galley, P.2
Manciet, G.3
-
55
-
-
0023751898
-
Position of tianeptine among antidepressive chemotherapies
-
Loo H, Deniker P. Position of tianeptine among antidepressive chemotherapies. Clin Neuropharmacol 1988;11:S97-S102.
-
(1988)
Clin Neuropharmacol
, vol.11
-
-
Loo, H.1
Deniker, P.2
-
56
-
-
0028966892
-
Tianeptine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression
-
Wilde MI, Benfield P. Tianeptine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression. Drugs 1995;49:411-39. Erratum in: Drugs 1995;50:156.
-
(1995)
Drugs
, vol.49
, pp. 411-439
-
-
Wilde, M.I.1
Benfield, P.2
-
57
-
-
0029039347
-
Erratum
-
Wilde MI, Benfield P. Tianeptine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression. Drugs 1995;49:411-39. Erratum in: Drugs 1995;50:156.
-
(1995)
Drugs
, vol.50
, pp. 156
-
-
-
58
-
-
0026630595
-
Clinical safety and efficacy of tianeptine in 1,858 depressed patients treated in general practice
-
Guelfi JD, Dulcire C, Le Moine P, et al. Clinical safety and efficacy of tianeptine in 1,858 depressed patients treated in general practice. Neuropsychobiology 1992;25:140-8.
-
(1992)
Neuropsychobiology
, vol.25
, pp. 140-148
-
-
Guelfi, J.D.1
Dulcire, C.2
Le Moine, P.3
-
59
-
-
0027942196
-
Tianeptine-an instance of drug-induced hepatotoxicity predicted by prospective experimental studies
-
Lebricquir Y, Larrey D, Blanc P, et al. Tianeptine-an instance of drug-induced hepatotoxicity predicted by prospective experimental studies. J Hepatol 1994;21:771-3.
-
(1994)
J Hepatol
, vol.21
, pp. 771-773
-
-
Lebricquir, Y.1
Larrey, D.2
Blanc, P.3
-
60
-
-
0025062545
-
Lack of cardiovascular side effects of the new tricyclic antidepressant tianeptine. A double-blind, placebo-controlled study in young healthy volunteers
-
Juvent M, Douchamps J, Delcourt E, et al. Lack of cardiovascular side effects of the new tricyclic antidepressant tianeptine. A double-blind, placebo-controlled study in young healthy volunteers. Clin Neuropharmacol 1990;13:48-57.
-
(1990)
Clin Neuropharmacol
, vol.13
, pp. 48-57
-
-
Juvent, M.1
Douchamps, J.2
Delcourt, E.3
-
61
-
-
0026424113
-
Cardiovascular tolerance to tianeptine (article in French)
-
Lasnier C, Marey C, Lapeyre G, et al. Cardiovascular tolerance to tianeptine (article in French). Presse Med 1991;20:1858-63.
-
(1991)
Presse Med
, vol.20
, pp. 1858-1863
-
-
Lasnier, C.1
Marey, C.2
Lapeyre, G.3
-
62
-
-
0035090020
-
Effects of tianeptine and mianserin on car driving skills
-
Ridout F, Hindmarch I. Effects of tianeptine and mianserin on car driving skills. Psychopharmacol 2001;154:356-61.
-
(2001)
Psychopharmacol
, vol.154
, pp. 356-361
-
-
Ridout, F.1
Hindmarch, I.2
-
63
-
-
0026595738
-
Long-term use of tianeptine in 380 depressed patients
-
Loo H, Ganry H, Dufour H, et al. Long-term use of tianeptine in 380 depressed patients. Br J Psychiatry (Suppl) 1992;15:61-5.
-
(1992)
Br J Psychiatry (Suppl)
, vol.15
, pp. 61-65
-
-
Loo, H.1
Ganry, H.2
Dufour, H.3
-
64
-
-
0033383906
-
Abuse of tianeptine. A case report
-
Vandel P, Regina W, Bonin B, et al. Abuse of tianeptine. A case report. Encephale 1999;25:672-3.
-
(1999)
Encephale
, vol.25
, pp. 672-673
-
-
Vandel, P.1
Regina, W.2
Bonin, B.3
-
65
-
-
0025332308
-
Pharmacokinetic and pharmacodynamic interaction between the antidepressant tianeptine and oxazepam at steady-state
-
Toon S, Holt BL, Langley SJ, et al. Pharmacokinetic and pharmacodynamic interaction between the antidepressant tianeptine and oxazepam at steady-state. Psychopharmacology 1990;101:226-32.
-
(1990)
Psychopharmacology
, vol.101
, pp. 226-232
-
-
Toon, S.1
Holt, B.L.2
Langley, S.J.3
-
66
-
-
0027272712
-
Behavioural and neurochemical evidence for the decrease of brain extracellular 5-HT by the antidepressant drug tianeptine
-
Datla KP, Curzon G. Behavioural and neurochemical evidence for the decrease of brain extracellular 5-HT by the antidepressant drug tianeptine. Neuropharmacology 1993;32:839-45.
-
(1993)
Neuropharmacology
, vol.32
, pp. 839-845
-
-
Datla, K.P.1
Curzon, G.2
-
67
-
-
0030700675
-
Efficacy of tianeptine in major depressive disorders with or without melancholia
-
Ginstet D. Efficacy of tianeptine in major depressive disorders with or without melancholia. Eur Neuropsychopharmacol 1997;7:S341-S345.
-
(1997)
Eur Neuropsychopharmacol
, vol.7
-
-
Ginstet, D.1
-
68
-
-
0031026851
-
Placebo-controlled study of tianeptine in major depressive episodes
-
Costa e Silva JA, Ruschel SI, Caetano D, et al. Placebo-controlled study of tianeptine in major depressive episodes. Neuropsychobiology 1997;35:24-9.
-
(1997)
Neuropsychobiology
, vol.35
, pp. 24-29
-
-
Costa E Silva, J.A.1
Ruschel, S.I.2
Caetano, D.3
-
69
-
-
0026512572
-
Efficacy of tianeptine in comparative trials versus reference antidepressants: An overview
-
Guelfi JD. Efficacy of tianeptine in comparative trials versus reference antidepressants: An overview. Br J Psychiatry (Suppl) 1992;15:72-5.
-
(1992)
Br J Psychiatry (Suppl)
, vol.15
, pp. 72-75
-
-
Guelfi, J.D.1
-
70
-
-
0028022056
-
The efficacy and safety of tianeptine in the treatment of depressive disorder: Results of a controlled double-blind multicenter study vs. amitriptyline
-
Invernizzi G, Aguglia E, Bertolino A, et al. The efficacy and safety of tianeptine in the treatment of depressive disorder: Results of a controlled double-blind multicenter study vs. amitriptyline. Neuropsychobiology 1994;30:85-93.
-
(1994)
Neuropsychobiology
, vol.30
, pp. 85-93
-
-
Invernizzi, G.1
Aguglia, E.2
Bertolino, A.3
-
71
-
-
0026735470
-
Efficacy of tianeptine in the treatment of psychasthenia: A study versus placebo
-
Grivois H, Deniker P, Ganry H. Efficacy of tianeptine in the treatment of psychasthenia: A study versus placebo. Encephale 1992;18:591-8.
-
(1992)
Encephale
, vol.18
, pp. 591-598
-
-
Grivois, H.1
Deniker, P.2
Ganry, H.3
-
72
-
-
0027303903
-
Anxiety-related and depressive disorders in women during the premenopausal and menopausal period: Study of the efficacy and acceptability of tianeptine versus maprotiline
-
Chaby L, Grinsztein A, Weitzman JJ, et al. Anxiety-related and depressive disorders in women during the premenopausal and menopausal period: Study of the efficacy and acceptability of tianeptine versus maprotiline. Presse Med 1993;22:1133-8.
-
(1993)
Presse Med
, vol.22
, pp. 1133-1138
-
-
Chaby, L.1
Grinsztein, A.2
Weitzman, J.J.3
-
73
-
-
0023821708
-
Tianeptine and amitriptyline: Controlled double-blind trial in depressed alcoholic patients
-
Loo H, Malka R, Defrance R, et al. Tianeptine and amitriptyline: Controlled double-blind trial in depressed alcoholic patients. Neuropsychobiology 1988;19:79-85.
-
(1988)
Neuropsychobiology
, vol.19
, pp. 79-85
-
-
Loo, H.1
Malka, R.2
Defrance, R.3
-
74
-
-
0024949963
-
Efficacy of tianeptine in anxious-depressed patients: Results of a controlled multicenter trial versus amitriptyline
-
Guelfi JD, Pichot P, Dreyfus JF. Efficacy of tianeptine in anxious-depressed patients: Results of a controlled multicenter trial versus amitriptyline. Neuropsychobiology 1989;22:41-8.
-
(1989)
Neuropsychobiology
, vol.22
, pp. 41-48
-
-
Guelfi, J.D.1
Pichot, P.2
Dreyfus, J.F.3
-
75
-
-
0032792342
-
The study of the efficacy of fluoxetine versus tianeptine in the treatment of elderly depressed patients followed in general practice
-
Guelfi JD, Bouhassira M, Bonett-Perrin E, et al. The study of the efficacy of fluoxetine versus tianeptine in the treatment of elderly depressed patients followed in general practice. Encephale 1999;25:265-70.
-
(1999)
Encephale
, vol.25
, pp. 265-270
-
-
Guelfi, J.D.1
Bouhassira, M.2
Bonett-Perrin, E.3
-
79
-
-
0030939231
-
Value of tianeptine in treating major recurrent unipolar depression: Study versus placebo for 16 1/2 months of treatment
-
Dalery J, Dagens-Lafant V, De Bodinat C. Value of tianeptine in treating major recurrent unipolar depression: Study versus placebo for 16 1/2 months of treatment. Encephale 1997;23:56-64.
-
(1997)
Encephale
, vol.23
, pp. 56-64
-
-
Dalery, J.1
Dagens-Lafant, V.2
De Bodinat, C.3
-
80
-
-
0025932550
-
Role of tianeptine in the prevention of depression relapse and recurrence: First estimations
-
Loo H, Ganry H, Dufour H, et al. Role of tianeptine in the prevention of depression relapse and recurrence: First estimations. Presse Med 1991;20:1864-8.
-
(1991)
Presse Med
, vol.20
, pp. 1864-1868
-
-
Loo, H.1
Ganry, H.2
Dufour, H.3
-
81
-
-
0026580267
-
Long-term administration of tianeptine in depressed patients after alcohol withdrawal
-
Malka R, Loo H, Ganry H, et al. Long-term administration of tianeptine in depressed patients after alcohol withdrawal. Br J Psychiatry (Suppl) 1992;15:66-71.
-
(1992)
Br J Psychiatry (Suppl)
, vol.15
, pp. 66-71
-
-
Malka, R.1
Loo, H.2
Ganry, H.3
|